Drug response profile-based machine learning enables strategic cell line and compound selection for drug development.

Saved in:
Bibliographic Details
Title: Drug response profile-based machine learning enables strategic cell line and compound selection for drug development.
Authors: Abdel-Rehim A; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, United Kingdom., Tate E; Arctoris Ltd, Abingdon, OX14 4SA, United Kingdom., Soldatova LN; Department of Mathematics, University College London, London, WC1H 0AY, United Kingdom., King RD; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, CB3 0AS, United Kingdom.; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, 412 96, Sweden.; Department of Computer Science and Engineering, Chalmers University of Technology, Gothenburg, 412 96, Sweden.; The Alan Turing Institute, London, NW1 2DB, United Kingdom.
Source: Bioinformatics (Oxford, England) [Bioinformatics] 2026 Jun 01; Vol. 42 (6).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9808944 Publication Model: Print Cited Medium: Internet ISSN: 1367-4811 (Electronic) Linking ISSN: 13674803 NLM ISO Abbreviation: Bioinformatics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1367-4811
DOI:10.1093/bioinformatics/btag293